SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '4bfr'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1CMA_B_SAMB105_0 (PROTEIN (MET REPRESSOR))	4bfr	PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC S SUBUNIT BETA ISOFORM (Mus musculus)	5 / 11	GLU A 981 ARG A 977 LEU A1032 ALA A 983 GLY A 901	None	1.26A	1cmaA-4bfrA: undetectable 1cmaB-4bfrA: undetectable	1cmaA-4bfrA: 7.47 1cmaB-4bfrA: 7.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1CMC_B_SAMB105_0 (MET REPRESSOR)	4bfr	PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC S SUBUNIT BETA ISOFORM (Mus musculus)	5 / 10	GLU A 981 ARG A 977 LEU A1032 ALA A 983 GLY A 901	None	1.29A	1cmcA-4bfrA: undetectable 1cmcB-4bfrA: undetectable	1cmcA-4bfrA: 7.47 1cmcB-4bfrA: 7.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1HK1_A_T44A3004_1 (SERUM ALBUMIN)	4bfr	PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC S SUBUNIT BETA ISOFORM (Mus musculus)	4 / 6	GLU A 180 LEU A 179 VAL A 267 MET A 268	None	1.05A	1hk1A-4bfrA: undetectable	1hk1A-4bfrA: 20.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1HK3_A_T44A3004_1 (SERUM ALBUMIN)	4bfr	PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC S SUBUNIT BETA ISOFORM (Mus musculus)	4 / 7	GLU A 180 LEU A 179 VAL A 267 MET A 268	None	1.01A	1hk3A-4bfrA: 1.2	1hk3A-4bfrA: 20.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1I9G_A_SAMA301_1 (HYPOTHETICAL PROTEIN RV2118C)	4bfr	PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC S SUBUNIT BETA ISOFORM (Mus musculus)	3 / 3	GLU A1008 HIS A 934 ASP A 807	None None J82 A2000 ( 4.9A)	0.79A	1i9gA-4bfrA: undetectable	1i9gA-4bfrA: 16.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1M4I_A_KANA500_1 (AMINOGLYCOSIDE 2'-N-ACETYLTRANSFERA SE)	4bfr	PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC S SUBUNIT BETA ISOFORM (Mus musculus)	4 / 8	ASP A 827 ASP A 818 GLY A 901 THR A 924	None	0.76A	1m4iA-4bfrA: undetectable	1m4iA-4bfrA: 11.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1MRL_A_DOLA300_1 (STREPTOGRAMIN A ACETYLTRANSFERASE)	4bfr	PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC S SUBUNIT BETA ISOFORM (Mus musculus)	5 / 11	ILE A 574 PRO A 389 LEU A 358 TYR A 642 ASP A 605	None	1.24A	1mrlA-4bfrA: undetectable 1mrlB-4bfrA: undetectable	1mrlA-4bfrA: 12.55 1mrlB-4bfrA: 12.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1OSV_B_CHCB201_1 (BILE ACID RECEPTOR)	4bfr	PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC S SUBUNIT BETA ISOFORM (Mus musculus)	5 / 12	LEU A 927 PHE A 952 SER A 906 ILE A 911 ILE A 919	None	1.36A	1osvB-4bfrA: undetectable	1osvB-4bfrA: 14.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1QKU_C_ESTC600_1 (ESTRADIOL RECEPTOR)	4bfr	PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC S SUBUNIT BETA ISOFORM (Mus musculus)	5 / 10	LEU A1002 MET A1001 LEU A1000 MET A 813 LEU A 936	None	1.46A	1qkuC-4bfrA: undetectable	1qkuC-4bfrA: 13.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1RL8_A_RITA9001_2 (PROTEASE RETROPEPSIN)	4bfr	PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC S SUBUNIT BETA ISOFORM (Mus musculus)	6 / 12	LEU A 909 GLY A 933 ASP A 913 ILE A 930 ALA A 905 ILE A 911	None None None J82 A2000 (-3.6A) None None	1.44A	1rl8B-4bfrA: undetectable	1rl8B-4bfrA: 8.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1RU9_H_ACTH611_0 (IMMUNOGLOBULIN IGG2A, HEAVY CHAIN IMMUNOGLOBULIN IGG2A, LIGHT CHAIN)	4bfr	PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC S SUBUNIT BETA ISOFORM (Mus musculus)	4 / 6	ASN A 468 LEU A 463 TRP A 434 PHE A 459	None	1.32A	1ru9H-4bfrA: undetectable 1ru9L-4bfrA: 3.1	1ru9H-4bfrA: 12.85 1ru9L-4bfrA: 11.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1RUK_L_ACTL611_0 (IMMUNOGLOBULIN IGG2A, HEAVY CHAIN IMMUNOGLOBULIN IGG2A, LIGHT CHAIN)	4bfr	PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC S SUBUNIT BETA ISOFORM (Mus musculus)	4 / 6	ASN A 468 LEU A 463 TRP A 434 PHE A 459	None	1.33A	1rukH-4bfrA: 3.1 1rukL-4bfrA: undetectable	1rukH-4bfrA: 12.85 1rukL-4bfrA: 11.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1TLM_A_MILA128_1 (TRANSTHYRETIN)	4bfr	PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC S SUBUNIT BETA ISOFORM (Mus musculus)	3 / 3	LEU A 567 LEU A 570 SER A 573	None	0.64A	1tlmA-4bfrA: 2.7	1tlmA-4bfrA: 8.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1WSV_A_THHA3001_0 (AMINOMETHYLTRANSFERA SE)	4bfr	PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC S SUBUNIT BETA ISOFORM (Mus musculus)	5 / 12	THR A 330 LEU A 331 ILE A 487 VAL A 451 PHE A 381	None	1.13A	1wsvA-4bfrA: undetectable	1wsvA-4bfrA: 17.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1WSV_B_THHB4001_0 (AMINOMETHYLTRANSFERA SE)	4bfr	PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC S SUBUNIT BETA ISOFORM (Mus musculus)	5 / 12	THR A 330 LEU A 331 ILE A 487 VAL A 451 PHE A 381	None	1.08A	1wsvB-4bfrA: undetectable	1wsvB-4bfrA: 17.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2A1H_A_GBNA502_1 (BRANCHED CHAIN AMINOTRANSFERASE)	4bfr	PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC S SUBUNIT BETA ISOFORM (Mus musculus)	4 / 8	GLY A 839 THR A 838 ALA A 837 VAL A 637	None	0.88A	2a1hA-4bfrA: undetectable 2a1hB-4bfrA: undetectable	2a1hA-4bfrA: 17.85 2a1hB-4bfrA: 17.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2CIZ_A_ACTA1321_0 (CHLOROPEROXIDASE)	4bfr	PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC S SUBUNIT BETA ISOFORM (Mus musculus)	4 / 5	LEU A 828 PHE A 976 VAL A 904 ALA A 983	None	1.20A	2cizA-4bfrA: undetectable	2cizA-4bfrA: 17.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2FT9_A_CHDA131_0 (FATTY ACID-BINDING PROTEIN 2, LIVER)	4bfr	PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC S SUBUNIT BETA ISOFORM (Mus musculus)	5 / 11	LEU A 936 LEU A 909 PRO A 540 ASN A 992 LEU A1006	None	1.23A	2ft9A-4bfrA: undetectable	2ft9A-4bfrA: 8.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2J9C_C_ACTC1120_0 (HYPOTHETICAL NITROGEN REGULATORY PII-LIKE PROTEIN MJ0059)	4bfr	PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC S SUBUNIT BETA ISOFORM (Mus musculus)	3 / 3	LYS A 569 TYR A 608 PRO A 568	None	1.46A	2j9cC-4bfrA: undetectable	2j9cC-4bfrA: 8.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2NYU_B_SAMB201_1 (PUTATIVE RIBOSOMAL RNA METHYLTRANSFERASE 2)	4bfr	PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC S SUBUNIT BETA ISOFORM (Mus musculus)	4 / 5	ALA A 583 ASP A 387 ASP A 382 ASP A 581	None	0.97A	2nyuB-4bfrA: undetectable	2nyuB-4bfrA: 12.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2W3A_B_TOPB1189_1 (DIHYDROFOLATE REDUCTASE)	4bfr	PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC S SUBUNIT BETA ISOFORM (Mus musculus)	5 / 10	ILE A 962 ALA A 900 PHE A 895 ILE A 854 LEU A 875	None	1.13A	2w3aB-4bfrA: undetectable	2w3aB-4bfrA: 12.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2W98_B_P1ZB1358_1 (PROSTAGLANDIN REDUCTASE 2)	4bfr	PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC S SUBUNIT BETA ISOFORM (Mus musculus)	4 / 6	ASP A 605 TYR A 642 PHE A 998 LEU A1009	None	1.19A	2w98A-4bfrA: undetectable 2w98B-4bfrA: undetectable	2w98A-4bfrA: 16.08 2w98B-4bfrA: 16.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y6N_D_DVAD8_0 (VAL-GRAMICIDIN A)	4bfr	PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC S SUBUNIT BETA ISOFORM (Mus musculus)	3 / 3	TRP A 434 VAL A 432 TRP A 456	None	1.31A	2y6nC-4bfrA: undetectable 2y6nD-4bfrA: undetectable	2y6nC-4bfrA: 1.45 2y6nD-4bfrA: 1.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y6N_F_DVAF8_0 (VAL-GRAMICIDIN A)	4bfr	PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC S SUBUNIT BETA ISOFORM (Mus musculus)	3 / 3	TRP A 434 VAL A 432 TRP A 456	None	1.34A	2y6nE-4bfrA: undetectable 2y6nF-4bfrA: undetectable	2y6nE-4bfrA: 1.45 2y6nF-4bfrA: 1.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2YGP_A_PCFA1213_0 (WNT INHIBITORY FACTOR 1)	4bfr	PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC S SUBUNIT BETA ISOFORM (Mus musculus)	5 / 12	LEU A 257 ILE A 215 PHE A 197 VAL A 195 VAL A 193	None	1.17A	2ygpA-4bfrA: undetectable	2ygpA-4bfrA: 11.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2ZM9_A_ACAA502_1 (6-AMINOHEXANOATE-DIM ER HYDROLASE)	4bfr	PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC S SUBUNIT BETA ISOFORM (Mus musculus)	4 / 8	ALA A 735 TYR A 772 HIS A 737 ILE A 720	None	0.88A	2zm9A-4bfrA: undetectable	2zm9A-4bfrA: 17.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3ADS_A_IMNA2_2 (PEROXISOME PROLIFERATOR-ACTIVAT ED RECEPTOR GAMMA)	4bfr	PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC S SUBUNIT BETA ISOFORM (Mus musculus)	4 / 6	ILE A 919 ILE A 935 LEU A 927 PHE A 928	None	0.78A	3adsA-4bfrA: undetectable	3adsA-4bfrA: 15.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3ADX_A_IMNA2_2 (PEROXISOME PROLIFERATOR-ACTIVAT ED RECEPTOR GAMMA)	4bfr	PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC S SUBUNIT BETA ISOFORM (Mus musculus)	4 / 7	ILE A 919 LEU A 927 PHE A 928 LEU A 811	None	0.94A	3adxA-4bfrA: undetectable	3adxA-4bfrA: 15.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3AG4_W_CHDW1059_0 (CYTOCHROME C OXIDASE POLYPEPTIDE 7A1 CYTOCHROME C OXIDASE SUBUNIT 1)	4bfr	PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC S SUBUNIT BETA ISOFORM (Mus musculus)	4 / 7	ILE A 329 LEU A 379 PHE A 381 ARG A 393	None	1.04A	3ag4N-4bfrA: undetectable 3ag4W-4bfrA: undetectable	3ag4N-4bfrA: 18.38 3ag4W-4bfrA: 4.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3ERD_A_DESA600_1 (ESTROGEN RECEPTOR ALPHA)	4bfr	PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC S SUBUNIT BETA ISOFORM (Mus musculus)	5 / 12	LEU A1009 LEU A1002 LEU A1000 MET A 813 LEU A 936	None	1.17A	3erdA-4bfrA: undetectable	3erdA-4bfrA: 15.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3JB3_A_SAMA1101_0 (STRUCTURAL PROTEIN VP3)	4bfr	PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC S SUBUNIT BETA ISOFORM (Mus musculus)	5 / 12	GLU A 249 ARG A 247 VAL A 193 ILE A 263 ASN A 265	None	1.35A	3jb3A-4bfrA: undetectable	3jb3A-4bfrA: 21.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3OLS_A_ESTA600_1 (ESTROGEN RECEPTOR BETA)	4bfr	PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC S SUBUNIT BETA ISOFORM (Mus musculus)	5 / 12	LEU A 816 LEU A 819 GLU A 823 GLY A 991 LEU A 987	None	1.13A	3olsA-4bfrA: undetectable	3olsA-4bfrA: 13.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3OLS_A_ESTA600_1 (ESTROGEN RECEPTOR BETA)	4bfr	PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC S SUBUNIT BETA ISOFORM (Mus musculus)	5 / 12	MET A 813 LEU A 816 LEU A 819 GLU A 823 GLY A 991	None	0.93A	3olsA-4bfrA: undetectable	3olsA-4bfrA: 13.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3T3S_D_9PLD1_1 (CYTOCHROME P450 2A13)	4bfr	PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC S SUBUNIT BETA ISOFORM (Mus musculus)	5 / 8	PHE A1039 PHE A1035 PHE A 952 ALA A 900 THR A 896	None	1.49A	3t3sD-4bfrA: undetectable	3t3sD-4bfrA: 18.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3THR_A_C2FA1100_1 (GLYCINE N-METHYLTRANSFERASE)	4bfr	PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC S SUBUNIT BETA ISOFORM (Mus musculus)	3 / 3	LEU A 740 HIS A 737 MET A 736	None	0.87A	3thrD-4bfrA: 2.1	3thrD-4bfrA: 15.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3UUD_B_ESTB600_1 (ESTROGEN RECEPTOR)	4bfr	PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC S SUBUNIT BETA ISOFORM (Mus musculus)	5 / 10	LEU A1002 MET A1001 LEU A1000 MET A 813 LEU A 936	None	1.38A	3uudB-4bfrA: undetectable	3uudB-4bfrA: 13.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3ZJQ_A_NCAA300_0 (PROTOGLOBIN)	4bfr	PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC S SUBUNIT BETA ISOFORM (Mus musculus)	5 / 7	VAL A 208 PHE A 206 VAL A 195 PHE A 275 ILE A 263	None	1.47A	3zjqA-4bfrA: undetectable	3zjqA-4bfrA: 11.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3ZJQ_B_NCAB300_0 (PROTOGLOBIN)	4bfr	PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC S SUBUNIT BETA ISOFORM (Mus musculus)	5 / 7	VAL A 208 PHE A 206 VAL A 195 PHE A 275 ILE A 263	None	1.45A	3zjqB-4bfrA: undetectable	3zjqB-4bfrA: 11.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4BQT_C_C5EC301_0 (SOLUBLE ACETYLCHOLINE RECEPTOR)	4bfr	PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC S SUBUNIT BETA ISOFORM (Mus musculus)	4 / 8	VAL A 921 TYR A 902 CYH A 899 ILE A 919	None	1.29A	4bqtC-4bfrA: undetectable 4bqtD-4bfrA: undetectable	4bqtC-4bfrA: 13.86 4bqtD-4bfrA: 13.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4E0F_A_RBFA301_2 (RIBOFLAVIN SYNTHASE SUBUNIT ALPHA)	4bfr	PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC S SUBUNIT BETA ISOFORM (Mus musculus)	3 / 3	LYS A1050 THR A 955 ILE A 962	None	0.83A	4e0fB-4bfrA: undetectable	4e0fB-4bfrA: 12.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4M51_A_BEZA501_0 (AMIDOHYDROLASE FAMILY PROTEIN)	4bfr	PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC S SUBUNIT BETA ISOFORM (Mus musculus)	4 / 6	ILE A 911 ARG A 914 ILE A 930 LEU A 811	None None J82 A2000 (-3.6A) None	0.99A	4m51A-4bfrA: undetectable	4m51A-4bfrA: 18.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4O8F_A_BRLA501_2 (PEROXISOME PROLIFERATOR-ACTIVAT ED RECEPTOR GAMMA)	4bfr	PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC S SUBUNIT BETA ISOFORM (Mus musculus)	4 / 5	GLY A 974 ILE A 962 LEU A 954 LEU A1032	None	0.78A	4o8fA-4bfrA: undetectable	4o8fA-4bfrA: 15.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4OBW_D_SAMD601_1 (2-METHOXY-6-POLYPREN YL-1,4-BENZOQUINOL METHYLASE, MITOCHONDRIAL)	4bfr	PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC S SUBUNIT BETA ISOFORM (Mus musculus)	3 / 3	ASN A 577 ASP A 581 ASP A 550	None	0.76A	4obwD-4bfrA: undetectable	4obwD-4bfrA: 14.63
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4XE0_A_40LA1101_0 (PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT DELTA ISOFORM)	4bfr	PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC S SUBUNIT BETA ISOFORM (Mus musculus)	5 / 12	ILE A 845 VAL A 848 THR A 853 MET A 920 ILE A 930	J82 A2000 ( 4.4A) J82 A2000 (-3.8A) None J82 A2000 (-3.6A) J82 A2000 (-3.6A)	1.08A	4xe0A-4bfrA: 40.7	4xe0A-4bfrA: 57.19
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4XE0_A_40LA1101_0 (PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT DELTA ISOFORM)	4bfr	PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC S SUBUNIT BETA ISOFORM (Mus musculus)	6 / 12	MET A 773 PRO A 779 TRP A 781 ILE A 797 ASP A 856 ASP A 931	J82 A2000 (-3.9A) J82 A2000 (-4.5A) None J82 A2000 (-4.4A) None J82 A2000 (-4.9A)	1.02A	4xe0A-4bfrA: 40.7	4xe0A-4bfrA: 57.19
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4XE0_A_40LA1101_0 (PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT DELTA ISOFORM)	4bfr	PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC S SUBUNIT BETA ISOFORM (Mus musculus)	6 / 12	MET A 773 PRO A 779 TRP A 781 ILE A 797 ASP A 856 ILE A 930	J82 A2000 (-3.9A) J82 A2000 (-4.5A) None J82 A2000 (-4.4A) None J82 A2000 (-3.6A)	1.05A	4xe0A-4bfrA: 40.7	4xe0A-4bfrA: 57.19
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4XE0_A_40LA1101_0 (PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT DELTA ISOFORM)	4bfr	PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC S SUBUNIT BETA ISOFORM (Mus musculus)	6 / 12	MET A 773 PRO A 779 TRP A 781 ILE A 797 TYR A 833 ILE A 930	J82 A2000 (-3.9A) J82 A2000 (-4.5A) None J82 A2000 (-4.4A) J82 A2000 (-3.7A) J82 A2000 (-3.6A)	0.90A	4xe0A-4bfrA: 40.7	4xe0A-4bfrA: 57.19
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4XE0_A_40LA1101_0 (PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT DELTA ISOFORM)	4bfr	PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC S SUBUNIT BETA ISOFORM (Mus musculus)	6 / 12	PRO A 779 TRP A 781 ILE A 797 ASP A 856 THR A 853 ASP A 931	J82 A2000 (-4.5A) None J82 A2000 (-4.4A) None None J82 A2000 (-4.9A)	1.40A	4xe0A-4bfrA: 40.7	4xe0A-4bfrA: 57.19
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4XE0_A_40LA1101_0 (PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT DELTA ISOFORM)	4bfr	PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC S SUBUNIT BETA ISOFORM (Mus musculus)	7 / 12	PRO A 779 TRP A 781 ILE A 797 ASP A 856 THR A 853 MET A 920 ILE A 930	J82 A2000 (-4.5A) None J82 A2000 (-4.4A) None None J82 A2000 (-3.6A) J82 A2000 (-3.6A)	1.28A	4xe0A-4bfrA: 40.7	4xe0A-4bfrA: 57.19
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4XE0_A_40LA1101_0 (PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT DELTA ISOFORM)	4bfr	PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC S SUBUNIT BETA ISOFORM (Mus musculus)	7 / 12	PRO A 779 TRP A 781 ILE A 797 TYR A 833 THR A 853 MET A 920 ILE A 930	J82 A2000 (-4.5A) None J82 A2000 (-4.4A) J82 A2000 (-3.7A) None J82 A2000 (-3.6A) J82 A2000 (-3.6A)	0.79A	4xe0A-4bfrA: 40.7	4xe0A-4bfrA: 57.19
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4XE0_A_40LA1101_0 (PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT DELTA ISOFORM)	4bfr	PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC S SUBUNIT BETA ISOFORM (Mus musculus)	7 / 12	TRP A 781 ILE A 797 TYR A 833 VAL A 848 THR A 853 MET A 920 ILE A 930	None J82 A2000 (-4.4A) J82 A2000 (-3.7A) J82 A2000 (-3.8A) None J82 A2000 (-3.6A) J82 A2000 (-3.6A)	0.75A	4xe0A-4bfrA: 40.7	4xe0A-4bfrA: 57.19
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4XE0_A_40LA1101_0 (PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT DELTA ISOFORM)	4bfr	PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC S SUBUNIT BETA ISOFORM (Mus musculus)	5 / 12	TYR A 833 VAL A 847 THR A 853 MET A 920 ILE A 930	J82 A2000 (-3.7A) J82 A2000 (-3.7A) None J82 A2000 (-3.6A) J82 A2000 (-3.6A)	1.38A	4xe0A-4bfrA: 40.7	4xe0A-4bfrA: 57.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5B1A_W_CHDW101_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL)	4bfr	PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC S SUBUNIT BETA ISOFORM (Mus musculus)	4 / 6	ILE A 329 LEU A 379 PHE A 381 ARG A 393	None	1.07A	5b1aN-4bfrA: undetectable 5b1aW-4bfrA: undetectable	5b1aN-4bfrA: 18.38 5b1aW-4bfrA: 4.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5B1B_W_CHDW101_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL)	4bfr	PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC S SUBUNIT BETA ISOFORM (Mus musculus)	4 / 7	ILE A 329 PHE A 489 ARG A 393 LEU A 388	None	0.92A	5b1bN-4bfrA: undetectable 5b1bW-4bfrA: undetectable	5b1bN-4bfrA: 18.38 5b1bW-4bfrA: 4.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5BS8_G_MFXG101_1 (DNA GYRASE SUBUNIT A DNA GYRASE SUBUNIT B DNA SUBSTRATE 24-MER TTACGTGCATAGTCATTCAT GACC)	4bfr	PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC S SUBUNIT BETA ISOFORM (Mus musculus)	5 / 7	ALA A 905 ASP A 827 ARG A 829 THR A 924 GLU A 894	None	1.17A	5bs8A-4bfrA: undetectable 5bs8C-4bfrA: undetectable 5bs8D-4bfrA: undetectable	5bs8A-4bfrA: 18.11 5bs8C-4bfrA: 18.11 5bs8D-4bfrA: 15.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5BTA_G_MFXG101_1 (DNA GYRASE SUBUNIT A DNA GYRASE SUBUNIT B DNA SUBSTRATE 24-MER TTACGTGCATAGTCATTCAT GACC)	4bfr	PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC S SUBUNIT BETA ISOFORM (Mus musculus)	4 / 7	ASP A 827 ARG A 829 THR A 924 GLU A 894	None	0.95A	5btaA-4bfrA: undetectable 5btaC-4bfrA: undetectable 5btaD-4bfrA: undetectable	5btaA-4bfrA: 18.21 5btaC-4bfrA: 18.21 5btaD-4bfrA: 15.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5BTF_F_GFNF101_1 (DNA GYRASE SUBUNIT A DNA GYRASE SUBUNIT B DNA SUBSTRATE 24-MER TTACGTGCATAGTCATTCAT GACC)	4bfr	PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC S SUBUNIT BETA ISOFORM (Mus musculus)	4 / 7	ASP A 827 ARG A 829 THR A 924 GLU A 894	None	0.98A	5btfA-4bfrA: 1.4 5btfB-4bfrA: undetectable 5btfC-4bfrA: 1.4	5btfA-4bfrA: 18.21 5btfB-4bfrA: 15.20 5btfC-4bfrA: 18.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5C0O_G_SAMG301_1 (TRNA (ADENINE(58)-N(1))-M ETHYLTRANSFERASE TRMI)	4bfr	PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC S SUBUNIT BETA ISOFORM (Mus musculus)	3 / 3	GLU A1008 HIS A 934 ASP A 807	None None J82 A2000 ( 4.9A)	0.72A	5c0oG-4bfrA: undetectable	5c0oG-4bfrA: 14.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ECL_A_ILEA602_0 (JASMONIC ACID-AMIDO SYNTHETASE JAR1)	4bfr	PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC S SUBUNIT BETA ISOFORM (Mus musculus)	4 / 6	ALA A 482 THR A 483 VAL A 435 HIS A 454	None	1.03A	5eclA-4bfrA: undetectable	5eclA-4bfrA: 21.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5HYR_B_ESTB601_1 (ESTROGEN RECEPTOR)	4bfr	PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC S SUBUNIT BETA ISOFORM (Mus musculus)	5 / 11	LEU A1002 MET A1001 LEU A1000 MET A 813 LEU A 936	None	1.42A	5hyrB-4bfrA: undetectable	5hyrB-4bfrA: 13.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5NFP_A_8W5A804_2 (GLUCOCORTICOID RECEPTOR)	4bfr	PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC S SUBUNIT BETA ISOFORM (Mus musculus)	4 / 4	LEU A 997 MET A 817 ILE A1015 LEU A 909	None	1.29A	5nfpA-4bfrA: undetectable	5nfpA-4bfrA: 15.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5WGQ_B_ESTB601_1 (ESTROGEN RECEPTOR)	4bfr	PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC S SUBUNIT BETA ISOFORM (Mus musculus)	5 / 10	LEU A1002 MET A1001 LEU A1000 MET A 813 LEU A 936	None	1.40A	5wgqB-4bfrA: 1.8	5wgqB-4bfrA: 6.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6BQG_A_ERMA1201_2 (5-HYDROXYTRYPTAMINE RECEPTOR 2C,SOLUBLE CYTOCHROME B562)	4bfr	PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC S SUBUNIT BETA ISOFORM (Mus musculus)	4 / 5	VAL A 439 LEU A 351 VAL A 362 LEU A 467	None	0.94A	6bqgA-4bfrA: undetectable	6bqgA-4bfrA: 6.31

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1CMA_B_SAMB105_0","PROTEIN (MET REPRESSOR)","4bfr","PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC S SUBUNIT BETA ISOFORM","Mus musculus",5,"GLU A 981;ARG A 977;LEU A1032;ALA A 983;GLY A 901","None","1.26A","1cmaA-4bfrA:undetectable;1cmaB-4bfrA:undetectable","1cmaA-4bfrA:7.47;1cmaB-4bfrA:7.47"],["1CMC_B_SAMB105_0","MET REPRESSOR","4bfr","PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC S SUBUNIT BETA ISOFORM","Mus musculus",5,"GLU A 981;ARG A 977;LEU A1032;ALA A 983;GLY A 901","None","1.29A","1cmcA-4bfrA:undetectable;1cmcB-4bfrA:undetectable","1cmcA-4bfrA:7.47;1cmcB-4bfrA:7.47"],["1HK1_A_T44A3004_1","SERUM ALBUMIN","4bfr","PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC S SUBUNIT BETA ISOFORM","Mus musculus",4,"GLU A 180;LEU A 179;VAL A 267;MET A 268","None","1.05A","1hk1A-4bfrA:undetectable","1hk1A-4bfrA:20.72"],["1HK3_A_T44A3004_1","SERUM ALBUMIN","4bfr","PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC S SUBUNIT BETA ISOFORM","Mus musculus",4,"GLU A 180;LEU A 179;VAL A 267;MET A 268","None","1.01A","1hk3A-4bfrA:1.2","1hk3A-4bfrA:20.72"],["1I9G_A_SAMA301_1","HYPOTHETICAL PROTEIN RV2118C","4bfr","PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC S SUBUNIT BETA ISOFORM","Mus musculus",3,"GLU A1008;HIS A 934;ASP A 807","None;None;J82 A2000 ( 4.9A)","0.79A","1i9gA-4bfrA:undetectable","1i9gA-4bfrA:16.93"],["1M4I_A_KANA500_1","AMINOGLYCOSIDE 2'-N-ACETYLTRANSFERASE","4bfr","PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC S SUBUNIT BETA ISOFORM","Mus musculus",4,"ASP A 827;ASP A 818;GLY A 901;THR A 924","None","0.76A","1m4iA-4bfrA:undetectable","1m4iA-4bfrA:11.49"],["1MRL_A_DOLA300_1","STREPTOGRAMIN A ACETYLTRANSFERASE;STREPTOGRAMIN A ACETYLTRANSFERASE","4bfr","PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC S SUBUNIT BETA ISOFORM","Mus musculus",5,"ILE A 574;PRO A 389;LEU A 358;TYR A 642;ASP A 605","None","1.24A","1mrlA-4bfrA:undetectable;1mrlB-4bfrA:undetectable","1mrlA-4bfrA:12.55;1mrlB-4bfrA:12.55"],["1OSV_B_CHCB201_1","BILE ACID RECEPTOR","4bfr","PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC S SUBUNIT BETA ISOFORM","Mus musculus",5,"LEU A 927;PHE A 952;SER A 906;ILE A 911;ILE A 919","None","1.36A","1osvB-4bfrA:undetectable","1osvB-4bfrA:14.09"],["1QKU_C_ESTC600_1","ESTRADIOL RECEPTOR","4bfr","PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC S SUBUNIT BETA ISOFORM","Mus musculus",5,"LEU A1002;MET A1001;LEU A1000;MET A 813;LEU A 936","None","1.46A","1qkuC-4bfrA:undetectable","1qkuC-4bfrA:13.20"],["1RL8_A_RITA9001_2","PROTEASE RETROPEPSIN;PROTEASE RETROPEPSIN","4bfr","PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC S SUBUNIT BETA ISOFORM","Mus musculus",6,"LEU A 909;GLY A 933;ASP A 913;ILE A 930;ALA A 905;ILE A 911","None;None;None;J82 A2000 (-3.6A);None;None","1.44A","1rl8B-4bfrA:undetectable","1rl8B-4bfrA:8.12"],["1RU9_H_ACTH611_0","IMMUNOGLOBULIN IGG2A, HEAVY CHAIN;IMMUNOGLOBULIN IGG2A, LIGHT CHAIN","4bfr","PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC S SUBUNIT BETA ISOFORM","Mus musculus",4,"ASN A 468;LEU A 463;TRP A 434;PHE A 459","None","1.32A","1ru9H-4bfrA:undetectable;1ru9L-4bfrA:3.1","1ru9H-4bfrA:12.85;1ru9L-4bfrA:11.83"],["1RUK_L_ACTL611_0","IMMUNOGLOBULIN IGG2A, HEAVY CHAIN;IMMUNOGLOBULIN IGG2A, LIGHT CHAIN","4bfr","PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC S SUBUNIT BETA ISOFORM","Mus musculus",4,"ASN A 468;LEU A 463;TRP A 434;PHE A 459","None","1.33A","1rukH-4bfrA:3.1;1rukL-4bfrA:undetectable","1rukH-4bfrA:12.85;1rukL-4bfrA:11.83"],["1TLM_A_MILA128_1","TRANSTHYRETIN","4bfr","PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC S SUBUNIT BETA ISOFORM","Mus musculus",3,"LEU A 567;LEU A 570;SER A 573","None","0.64A","1tlmA-4bfrA:2.7","1tlmA-4bfrA:8.85"],["1WSV_A_THHA3001_0","AMINOMETHYLTRANSFERASE","4bfr","PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC S SUBUNIT BETA ISOFORM","Mus musculus",5,"THR A 330;LEU A 331;ILE A 487;VAL A 451;PHE A 381","None","1.13A","1wsvA-4bfrA:undetectable","1wsvA-4bfrA:17.74"],["1WSV_B_THHB4001_0","AMINOMETHYLTRANSFERASE","4bfr","PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC S SUBUNIT BETA ISOFORM","Mus musculus",5,"THR A 330;LEU A 331;ILE A 487;VAL A 451;PHE A 381","None","1.08A","1wsvB-4bfrA:undetectable","1wsvB-4bfrA:17.74"],["2A1H_A_GBNA502_1","BRANCHED CHAIN AMINOTRANSFERASE;BRANCHED CHAIN AMINOTRANSFERASE","4bfr","PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC S SUBUNIT BETA ISOFORM","Mus musculus",4,"GLY A 839;THR A 838;ALA A 837;VAL A 637","None","0.88A","2a1hA-4bfrA:undetectable;2a1hB-4bfrA:undetectable","2a1hA-4bfrA:17.85;2a1hB-4bfrA:17.85"],["2CIZ_A_ACTA1321_0","CHLOROPEROXIDASE","4bfr","PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC S SUBUNIT BETA ISOFORM","Mus musculus",4,"LEU A 828;PHE A 976;VAL A 904;ALA A 983","None","1.20A","2cizA-4bfrA:undetectable","2cizA-4bfrA:17.21"],["2FT9_A_CHDA131_0","FATTY ACID-BINDING PROTEIN 2, LIVER","4bfr","PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC S SUBUNIT BETA ISOFORM","Mus musculus",5,"LEU A 936;LEU A 909;PRO A 540;ASN A 992;LEU A1006","None","1.23A","2ft9A-4bfrA:undetectable","2ft9A-4bfrA:8.84"],["2J9C_C_ACTC1120_0","HYPOTHETICAL NITROGEN REGULATORY PII-LIKE PROTEIN MJ0059","4bfr","PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC S SUBUNIT BETA ISOFORM","Mus musculus",3,"LYS A 569;TYR A 608;PRO A 568","None","1.46A","2j9cC-4bfrA:undetectable","2j9cC-4bfrA:8.05"],["2NYU_B_SAMB201_1","PUTATIVE RIBOSOMAL RNA METHYLTRANSFERASE 2","4bfr","PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC S SUBUNIT BETA ISOFORM","Mus musculus",4,"ALA A 583;ASP A 387;ASP A 382;ASP A 581","None","0.97A","2nyuB-4bfrA:undetectable","2nyuB-4bfrA:12.33"],["2W3A_B_TOPB1189_1","DIHYDROFOLATE REDUCTASE","4bfr","PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC S SUBUNIT BETA ISOFORM","Mus musculus",5,"ILE A 962;ALA A 900;PHE A 895;ILE A 854;LEU A 875","None","1.13A","2w3aB-4bfrA:undetectable","2w3aB-4bfrA:12.12"],["2W98_B_P1ZB1358_1","PROSTAGLANDIN REDUCTASE 2;PROSTAGLANDIN REDUCTASE 2","4bfr","PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC S SUBUNIT BETA ISOFORM","Mus musculus",4,"ASP A 605;TYR A 642;PHE A 998;LEU A1009","None","1.19A","2w98A-4bfrA:undetectable;2w98B-4bfrA:undetectable","2w98A-4bfrA:16.08;2w98B-4bfrA:16.08"],["2Y6N_D_DVAD8_0","VAL-GRAMICIDIN A","4bfr","PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC S SUBUNIT BETA ISOFORM","Mus musculus",3,"TRP A 434;VAL A 432;TRP A 456","None","1.31A","2y6nC-4bfrA:undetectable;2y6nD-4bfrA:undetectable","2y6nC-4bfrA:1.45;2y6nD-4bfrA:1.45"],["2Y6N_F_DVAF8_0","VAL-GRAMICIDIN A","4bfr","PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC S SUBUNIT BETA ISOFORM","Mus musculus",3,"TRP A 434;VAL A 432;TRP A 456","None","1.34A","2y6nE-4bfrA:undetectable;2y6nF-4bfrA:undetectable","2y6nE-4bfrA:1.45;2y6nF-4bfrA:1.45"],["2YGP_A_PCFA1213_0","WNT INHIBITORY FACTOR 1","4bfr","PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC S SUBUNIT BETA ISOFORM","Mus musculus",5,"LEU A 257;ILE A 215;PHE A 197;VAL A 195;VAL A 193","None","1.17A","2ygpA-4bfrA:undetectable","2ygpA-4bfrA:11.35"],["2ZM9_A_ACAA502_1","6-AMINOHEXANOATE-DIMER HYDROLASE","4bfr","PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC S SUBUNIT BETA ISOFORM","Mus musculus",4,"ALA A 735;TYR A 772;HIS A 737;ILE A 720","None","0.88A","2zm9A-4bfrA:undetectable","2zm9A-4bfrA:17.59"],["3ADS_A_IMNA2_2","PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA","4bfr","PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC S SUBUNIT BETA ISOFORM","Mus musculus",4,"ILE A 919;ILE A 935;LEU A 927;PHE A 928","None","0.78A","3adsA-4bfrA:undetectable","3adsA-4bfrA:15.46"],["3ADX_A_IMNA2_2","PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA","4bfr","PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC S SUBUNIT BETA ISOFORM","Mus musculus",4,"ILE A 919;LEU A 927;PHE A 928;LEU A 811","None","0.94A","3adxA-4bfrA:undetectable","3adxA-4bfrA:15.46"],["3AG4_W_CHDW1059_0","CYTOCHROME C OXIDASE POLYPEPTIDE 7A1;CYTOCHROME C OXIDASE SUBUNIT 1","4bfr","PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC S SUBUNIT BETA ISOFORM","Mus musculus",4,"ILE A 329;LEU A 379;PHE A 381;ARG A 393","None","1.04A","3ag4N-4bfrA:undetectable;3ag4W-4bfrA:undetectable","3ag4N-4bfrA:18.38;3ag4W-4bfrA:4.75"],["3ERD_A_DESA600_1","ESTROGEN RECEPTOR ALPHA","4bfr","PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC S SUBUNIT BETA ISOFORM","Mus musculus",5,"LEU A1009;LEU A1002;LEU A1000;MET A 813;LEU A 936","None","1.17A","3erdA-4bfrA:undetectable","3erdA-4bfrA:15.15"],["3JB3_A_SAMA1101_0","STRUCTURAL PROTEIN VP3","4bfr","PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC S SUBUNIT BETA ISOFORM","Mus musculus",5,"GLU A 249;ARG A 247;VAL A 193;ILE A 263;ASN A 265","None","1.35A","3jb3A-4bfrA:undetectable","3jb3A-4bfrA:21.49"],["3OLS_A_ESTA600_1","ESTROGEN RECEPTOR BETA","4bfr","PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC S SUBUNIT BETA ISOFORM","Mus musculus",5,"LEU A 816;LEU A 819;GLU A 823;GLY A 991;LEU A 987","None","1.13A","3olsA-4bfrA:undetectable","3olsA-4bfrA:13.25"],["3OLS_A_ESTA600_1","ESTROGEN RECEPTOR BETA","4bfr","PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC S SUBUNIT BETA ISOFORM","Mus musculus",5,"MET A 813;LEU A 816;LEU A 819;GLU A 823;GLY A 991","None","0.93A","3olsA-4bfrA:undetectable","3olsA-4bfrA:13.25"],["3T3S_D_9PLD1_1","CYTOCHROME P450 2A13","4bfr","PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC S SUBUNIT BETA ISOFORM","Mus musculus",5,"PHE A1039;PHE A1035;PHE A 952;ALA A 900;THR A 896","None","1.49A","3t3sD-4bfrA:undetectable","3t3sD-4bfrA:18.52"],["3THR_A_C2FA1100_1","GLYCINE N-METHYLTRANSFERASE","4bfr","PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC S SUBUNIT BETA ISOFORM","Mus musculus",3,"LEU A 740;HIS A 737;MET A 736","None","0.87A","3thrD-4bfrA:2.1","3thrD-4bfrA:15.78"],["3UUD_B_ESTB600_1","ESTROGEN RECEPTOR","4bfr","PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC S SUBUNIT BETA ISOFORM","Mus musculus",5,"LEU A1002;MET A1001;LEU A1000;MET A 813;LEU A 936","None","1.38A","3uudB-4bfrA:undetectable","3uudB-4bfrA:13.13"],["3ZJQ_A_NCAA300_0","PROTOGLOBIN","4bfr","PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC S SUBUNIT BETA ISOFORM","Mus musculus",5,"VAL A 208;PHE A 206;VAL A 195;PHE A 275;ILE A 263","None","1.47A","3zjqA-4bfrA:undetectable","3zjqA-4bfrA:11.50"],["3ZJQ_B_NCAB300_0","PROTOGLOBIN","4bfr","PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC S SUBUNIT BETA ISOFORM","Mus musculus",5,"VAL A 208;PHE A 206;VAL A 195;PHE A 275;ILE A 263","None","1.45A","3zjqB-4bfrA:undetectable","3zjqB-4bfrA:11.50"],["4BQT_C_C5EC301_0","SOLUBLE ACETYLCHOLINE RECEPTOR","4bfr","PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC S SUBUNIT BETA ISOFORM","Mus musculus",4,"VAL A 921;TYR A 902;CYH A 899;ILE A 919","None","1.29A","4bqtC-4bfrA:undetectable;4bqtD-4bfrA:undetectable","4bqtC-4bfrA:13.86;4bqtD-4bfrA:13.86"],["4E0F_A_RBFA301_2","RIBOFLAVIN SYNTHASE SUBUNIT ALPHA;RIBOFLAVIN SYNTHASE SUBUNIT ALPHA","4bfr","PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC S SUBUNIT BETA ISOFORM","Mus musculus",3,"LYS A1050;THR A 955;ILE A 962","None","0.83A","4e0fB-4bfrA:undetectable","4e0fB-4bfrA:12.37"],["4M51_A_BEZA501_0","AMIDOHYDROLASE FAMILY PROTEIN","4bfr","PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC S SUBUNIT BETA ISOFORM","Mus musculus",4,"ILE A 911;ARG A 914;ILE A 930;LEU A 811","None;None;J82 A2000 (-3.6A);None","0.99A","4m51A-4bfrA:undetectable","4m51A-4bfrA:18.56"],["4O8F_A_BRLA501_2","PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA","4bfr","PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC S SUBUNIT BETA ISOFORM","Mus musculus",4,"GLY A 974;ILE A 962;LEU A 954;LEU A1032","None","0.78A","4o8fA-4bfrA:undetectable","4o8fA-4bfrA:15.46"],["4OBW_D_SAMD601_1","2-METHOXY-6-POLYPRENYL-1,4-BENZOQUINOL METHYLASE, MITOCHONDRIAL","4bfr","PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC S SUBUNIT BETA ISOFORM","Mus musculus",3,"ASN A 577;ASP A 581;ASP A 550","None","0.76A","4obwD-4bfrA:undetectable","4obwD-4bfrA:14.63"],["4XE0_A_40LA1101_0","PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT DELTA ISOFORM","4bfr","PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC S SUBUNIT BETA ISOFORM","Mus musculus",5,"ILE A 845;VAL A 848;THR A 853;MET A 920;ILE A 930","J82 A2000 ( 4.4A);J82 A2000 (-3.8A);None;J82 A2000 (-3.6A);J82 A2000 (-3.6A)","1.08A","4xe0A-4bfrA:40.7","4xe0A-4bfrA:57.19"],["4XE0_A_40LA1101_0","PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT DELTA ISOFORM","4bfr","PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC S SUBUNIT BETA ISOFORM","Mus musculus",6,"MET A 773;PRO A 779;TRP A 781;ILE A 797;ASP A 856;ASP A 931","J82 A2000 (-3.9A);J82 A2000 (-4.5A);None;J82 A2000 (-4.4A);None;J82 A2000 (-4.9A)","1.02A","4xe0A-4bfrA:40.7","4xe0A-4bfrA:57.19"],["4XE0_A_40LA1101_0","PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT DELTA ISOFORM","4bfr","PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC S SUBUNIT BETA ISOFORM","Mus musculus",6,"MET A 773;PRO A 779;TRP A 781;ILE A 797;ASP A 856;ILE A 930","J82 A2000 (-3.9A);J82 A2000 (-4.5A);None;J82 A2000 (-4.4A);None;J82 A2000 (-3.6A)","1.05A","4xe0A-4bfrA:40.7","4xe0A-4bfrA:57.19"],["4XE0_A_40LA1101_0","PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT DELTA ISOFORM","4bfr","PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC S SUBUNIT BETA ISOFORM","Mus musculus",6,"MET A 773;PRO A 779;TRP A 781;ILE A 797;TYR A 833;ILE A 930","J82 A2000 (-3.9A);J82 A2000 (-4.5A);None;J82 A2000 (-4.4A);J82 A2000 (-3.7A);J82 A2000 (-3.6A)","0.90A","4xe0A-4bfrA:40.7","4xe0A-4bfrA:57.19"],["4XE0_A_40LA1101_0","PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT DELTA ISOFORM","4bfr","PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC S SUBUNIT BETA ISOFORM","Mus musculus",6,"PRO A 779;TRP A 781;ILE A 797;ASP A 856;THR A 853;ASP A 931","J82 A2000 (-4.5A);None;J82 A2000 (-4.4A);None;None;J82 A2000 (-4.9A)","1.40A","4xe0A-4bfrA:40.7","4xe0A-4bfrA:57.19"],["4XE0_A_40LA1101_0","PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT DELTA ISOFORM","4bfr","PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC S SUBUNIT BETA ISOFORM","Mus musculus",7,"PRO A 779;TRP A 781;ILE A 797;ASP A 856;THR A 853;MET A 920;ILE A 930","J82 A2000 (-4.5A);None;J82 A2000 (-4.4A);None;None;J82 A2000 (-3.6A);J82 A2000 (-3.6A)","1.28A","4xe0A-4bfrA:40.7","4xe0A-4bfrA:57.19"],["4XE0_A_40LA1101_0","PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT DELTA ISOFORM","4bfr","PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC S SUBUNIT BETA ISOFORM","Mus musculus",7,"PRO A 779;TRP A 781;ILE A 797;TYR A 833;THR A 853;MET A 920;ILE A 930","J82 A2000 (-4.5A);None;J82 A2000 (-4.4A);J82 A2000 (-3.7A);None;J82 A2000 (-3.6A);J82 A2000 (-3.6A)","0.79A","4xe0A-4bfrA:40.7","4xe0A-4bfrA:57.19"],["4XE0_A_40LA1101_0","PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT DELTA ISOFORM","4bfr","PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC S SUBUNIT BETA ISOFORM","Mus musculus",7,"TRP A 781;ILE A 797;TYR A 833;VAL A 848;THR A 853;MET A 920;ILE A 930","None;J82 A2000 (-4.4A);J82 A2000 (-3.7A);J82 A2000 (-3.8A);None;J82 A2000 (-3.6A);J82 A2000 (-3.6A)","0.75A","4xe0A-4bfrA:40.7","4xe0A-4bfrA:57.19"],["4XE0_A_40LA1101_0","PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT DELTA ISOFORM","4bfr","PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC S SUBUNIT BETA ISOFORM","Mus musculus",5,"TYR A 833;VAL A 847;THR A 853;MET A 920;ILE A 930","J82 A2000 (-3.7A);J82 A2000 (-3.7A);None;J82 A2000 (-3.6A);J82 A2000 (-3.6A)","1.38A","4xe0A-4bfrA:40.7","4xe0A-4bfrA:57.19"],["5B1A_W_CHDW101_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL","4bfr","PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC S SUBUNIT BETA ISOFORM","Mus musculus",4,"ILE A 329;LEU A 379;PHE A 381;ARG A 393","None","1.07A","5b1aN-4bfrA:undetectable;5b1aW-4bfrA:undetectable","5b1aN-4bfrA:18.38;5b1aW-4bfrA:4.75"],["5B1B_W_CHDW101_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL","4bfr","PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC S SUBUNIT BETA ISOFORM","Mus musculus",4,"ILE A 329;PHE A 489;ARG A 393;LEU A 388","None","0.92A","5b1bN-4bfrA:undetectable;5b1bW-4bfrA:undetectable","5b1bN-4bfrA:18.38;5b1bW-4bfrA:4.75"],["5BS8_G_MFXG101_1","DNA GYRASE SUBUNIT A;DNA GYRASE SUBUNIT A;DNA GYRASE SUBUNIT B;DNA SUBSTRATE 24-MER TTACGTGCATAGTCATTCATGACC","4bfr","PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC S SUBUNIT BETA ISOFORM","Mus musculus",5,"ALA A 905;ASP A 827;ARG A 829;THR A 924;GLU A 894","None","1.17A","5bs8A-4bfrA:undetectable;5bs8C-4bfrA:undetectable;5bs8D-4bfrA:undetectable","5bs8A-4bfrA:18.11;5bs8C-4bfrA:18.11;5bs8D-4bfrA:15.20"],["5BTA_G_MFXG101_1","DNA GYRASE SUBUNIT A;DNA GYRASE SUBUNIT A;DNA GYRASE SUBUNIT B;DNA SUBSTRATE 24-MER TTACGTGCATAGTCATTCATGACC","4bfr","PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC S SUBUNIT BETA ISOFORM","Mus musculus",4,"ASP A 827;ARG A 829;THR A 924;GLU A 894","None","0.95A","5btaA-4bfrA:undetectable;5btaC-4bfrA:undetectable;5btaD-4bfrA:undetectable","5btaA-4bfrA:18.21;5btaC-4bfrA:18.21;5btaD-4bfrA:15.20"],["5BTF_F_GFNF101_1","DNA GYRASE SUBUNIT A;DNA GYRASE SUBUNIT B;DNA GYRASE SUBUNIT A;DNA SUBSTRATE 24-MER TTACGTGCATAGTCATTCATGACC","4bfr","PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC S SUBUNIT BETA ISOFORM","Mus musculus",4,"ASP A 827;ARG A 829;THR A 924;GLU A 894","None","0.98A","5btfA-4bfrA:1.4;5btfB-4bfrA:undetectable;5btfC-4bfrA:1.4","5btfA-4bfrA:18.21;5btfB-4bfrA:15.20;5btfC-4bfrA:18.21"],["5C0O_G_SAMG301_1","TRNA (ADENINE(58)-N(1))-METHYLTRANSFERASE TRMI","4bfr","PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC S SUBUNIT BETA ISOFORM","Mus musculus",3,"GLU A1008;HIS A 934;ASP A 807","None;None;J82 A2000 ( 4.9A)","0.72A","5c0oG-4bfrA:undetectable","5c0oG-4bfrA:14.71"],["5ECL_A_ILEA602_0","JASMONIC ACID-AMIDO SYNTHETASE JAR1","4bfr","PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC S SUBUNIT BETA ISOFORM","Mus musculus",4,"ALA A 482;THR A 483;VAL A 435;HIS A 454","None","1.03A","5eclA-4bfrA:undetectable","5eclA-4bfrA:21.03"],["5HYR_B_ESTB601_1","ESTROGEN RECEPTOR","4bfr","PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC S SUBUNIT BETA ISOFORM","Mus musculus",5,"LEU A1002;MET A1001;LEU A1000;MET A 813;LEU A 936","None","1.42A","5hyrB-4bfrA:undetectable","5hyrB-4bfrA:13.43"],["5NFP_A_8W5A804_2","GLUCOCORTICOID RECEPTOR","4bfr","PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC S SUBUNIT BETA ISOFORM","Mus musculus",4,"LEU A 997;MET A 817;ILE A1015;LEU A 909","None","1.29A","5nfpA-4bfrA:undetectable","5nfpA-4bfrA:15.38"],["5WGQ_B_ESTB601_1","ESTROGEN RECEPTOR","4bfr","PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC S SUBUNIT BETA ISOFORM","Mus musculus",5,"LEU A1002;MET A1001;LEU A1000;MET A 813;LEU A 936","None","1.40A","5wgqB-4bfrA:1.8","5wgqB-4bfrA:6.04"],["6BQG_A_ERMA1201_2","5-HYDROXYTRYPTAMINE RECEPTOR 2C,SOLUBLE CYTOCHROME B562","4bfr","PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC S SUBUNIT BETA ISOFORM","Mus musculus",4,"VAL A 439;LEU A 351;VAL A 362;LEU A 467","None","0.94A","6bqgA-4bfrA:undetectable","6bqgA-4bfrA:6.31"]]